Latest Story
Director dealings: Hikma Pharmaceuticals director raises stake
By Iain Gilbert
Date: Friday 22 Aug 2025
(Sharecast News) - Hikma Pharmaceuticals revealed on Friday that non-executive director Laura Balan had acquired 3,500 ordinary shares in the FTSE 100-listed drugmaker.
Balan, who was appointed to the board of Hikma in 2022, purchased the shares at an average price of 1,820.70p each, for a total value of £63,724.50.
or login to read the full story
Email this article to a friend
or share it with one of these popular networks:
Article Archive
You are here: news
